EIF4E and cancer: MKNK1 is target of both RAS/RAF/ERK and MKK/p38 MAPK pathways [55] and regulates the activation of eIF4E (eukaryotic translation initiation factor 4E), strongly upregulated in cancer patients and correlated with disease progression [56,57].